Neuromyelitis Optica Spectrum Disorders - Globe Thesis

Keyword [Neuromyelitis Optica Spectrum Disorders] Result: 21 - 40 \| Page: 2 of 5
21.	The Analysis Of Related Factors For Optic Neuropathy In Patients With Neuromyelitis Optica Spectrum Disorders
22.	Lead Design For Classical Autoimmune Reaction Of Neuromyelitis Optica Spectrum Disorders
23.	Detection Of Serum AQP4-M23-IgG And Its Immunal Effect In Stomach,Labial Gland,Skeletal Muscle And Kidney Of Patients With NMOSDs
24.	The Correlative Study Between Aquaporin-4 Antibodies And Retinal Nerve Fiber Layer And Macular Injury In Neuromyelitis Optica Spectrum Disorders
25.	Clinical Evaluation Of AQP4-IgG For Neuromyelitis Optica Spectrum Disorders
26.	The Clinical Significance Of Lymphocyte Subsets And Serum IL-35 Level In Patients With Neuromyelitis Optica Spectrum Disorders
27.	The Role Of Regulatory B Cells In Neuromyelitis Optica Spectrum Disorders
28.	The Roles Of Follicular Helper T Cell And CXCL13 In Neuromyelitis Optica Spectrum Disorders
29.	Diagnostic Value Of Pruritus On Neuromyelitis Optica Spectrum Disorders And OCT Study
30.	Effects Of Comprehensive Rehabilitation Therapy In Adult With Neuromyelitis Optica And Multiple Sclerosis
31.	Low CD59 Expression On Astrocyte Contributes To Central Nervous System-restricted Lesion Development In Neuromyelitis Optica Spectrum Disorders
32.	Efficacy And Safety Of Tacrolimus Treatment For Neuromyelitis Optica Spectrum Disorders
33.	Alterations Of Brian Function,AQP4-IgG Subtype Distribution And Prevention Treatment Of Neuromyelitis Optica Spectrum Disorders
34.	The Correlative Study Of Serum Anti-AQP4 Antibody And Autoantibodies On Neuromyelitis Optica Spectrum And Non-organ Specific Autoimmune Disease
35.	Functional Connectivity Density And Functional Connectivity Of Default Mode Network And Frontoparietal Network Alterations At Resting State In Neuromyelitis Optica Spectrum Disorders Patients
36.	3.0T Head And Spinal Cord MRI Research In The Diagnosis Of Neuromyelitis Optica Spectrum Disorders
37.	A Retrospective Analysis Of Clinically Isolated Syndrome
38.	The Impact Of Intravenous Drugs With Intrathecal Injection In The Treatment Of Acute Neuromyelitis Optica Spectrum Disorders
39.	Study On The Correlation Between Serum Level Of Semaphorin3A Protein And The Clinical Features Of Neuromyelitis Optica Spectrum Disorders
40.	A Study Of Clinical Features Of Patients Diagnosed With Neuromyelitis Optica Spectrum Disorders Who Were Both AQP4-Ab Seropositive And Other Autoantibodies Seropositive
<<First <Prev Next> Last>> Jump to